Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Yeast Signaling01:28

Yeast Signaling

Yeasts are single-celled organisms, but unlike bacteria, they are eukaryotes (cells with a nucleus). Cell signaling in yeast is similar to signaling in other eukaryotic cells. A ligand, such as a protein or a small molecule released from a yeast cell, attaches to a receptor on the cell surface. The binding stimulates second-messenger kinases to activate or inactivate transcription factors that further regulate gene expression. Many of the yeast intracellular signaling cascades have similar...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering Single-Chain Antibody Fragment (scFv) Variants Targeting A Disintegrin and Metalloproteinase-17 (ADAM-17).

Biomolecules·2026
Same author

Evaluating the effect of minimal TIMP variants on protecting and transport across the rat brain microvascular cells (RBMEC).

Scientific reports·2025
Same author

Directed evolution of metalloproteinase inhibitor TIMP-1 for selective inhibition of MMP-9 exploits catalytic and fibronectin domain interactions.

The Journal of biological chemistry·2025
Same author

Effect of TIMPs and their minimally engineered variants in blocking invasion and migration of brain cancer cells.

Oncotarget·2025
Same author

Determining key residues of engineered scFv antibody variants with improved MMP-9 binding using deep sequencing and machine learning.

Computational and structural biotechnology journal·2024
Same author

Elucidating key determinants of engineered scFv antibody in MMP-9 binding using high throughput screening and machine learning.

bioRxiv : the preprint server for biology·2024
Same journal

Targeting CD8+ T Cell-Derived Granzyme K Alleviates Radiation-Induced Pulmonary Fibrosis by Attenuating Senescence and SASP.

Archives of biochemistry and biophysics·2026
Same journal

The Binding Affinity and Recognition Specificity of Dopamine to Human Dopamine Receptors can be Rationally Altered by Halogen Doping.

Archives of biochemistry and biophysics·2026
Same journal

Cortical Cholesterol Deficit and Reduced Network Excitability in ApoE-Deficient Mice.

Archives of biochemistry and biophysics·2026
Same journal

Unraveling zinc's impact: Variable effects across concentrations in Phaseolus coccineus thylakoids.

Archives of biochemistry and biophysics·2026
Same journal

Characterizing tumor-associated endothelial cells in clear cell renal cell carcinoma via scRNA-seq and Bulk RNA-seq: construction of a prognostic risk signature.

Archives of biochemistry and biophysics·2026
Same journal

FOSB-Histone deacetylase 6 axis drives hepcidin-mediated ferroptosis in pulmonary ischemia-reperfusion injury.

Archives of biochemistry and biophysics·2026
See all related articles

Related Experiment Video

Updated: May 23, 2026

Protein Engineering by Yeast Surface Display
05:49

Protein Engineering by Yeast Surface Display

Published on: November 29, 2024

Engineering antibodies by yeast display.

Eric T Boder1, Maryam Raeeszadeh-Sarmazdeh, J Vincent Price

  • 1Department of Chemical and Biomolecular Engineering, University of Tennessee, Knoxville, TN 37996-2200, USA. boder@utk.edu

Archives of Biochemistry and Biophysics
|March 28, 2012
PubMed
Summary
This summary is machine-generated.

Yeast display technology has advanced antibody engineering over 15 years, enabling affinity maturation and novel antibody isolation. This powerful method enhances engineered molecule quality and success rates in antibody campaigns.

More Related Videos

Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments
12:28

Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments

Published on: October 15, 2016

Enzymatic Modification and Flow Cytometry Assessment of Yeast Surface Displayed Proteins
10:54

Enzymatic Modification and Flow Cytometry Assessment of Yeast Surface Displayed Proteins

Published on: May 30, 2025

Related Experiment Videos

Last Updated: May 23, 2026

Protein Engineering by Yeast Surface Display
05:49

Protein Engineering by Yeast Surface Display

Published on: November 29, 2024

Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments
12:28

Bacterial Inner-membrane Display for Screening a Library of Antibody Fragments

Published on: October 15, 2016

Enzymatic Modification and Flow Cytometry Assessment of Yeast Surface Displayed Proteins
10:54

Enzymatic Modification and Flow Cytometry Assessment of Yeast Surface Displayed Proteins

Published on: May 30, 2025

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Immunology

Background:

  • Yeast display technology has been utilized for antibody engineering for 15 years.
  • It has become a potent tool for affinity maturation and isolation of novel antibodies and antibody-like species.
  • Robust methods for diversity creation, library construction, and screening have been developed.

Purpose of the Study:

  • To summarize the history and applications of antibody engineering using yeast surface display.
  • To highlight the utility of yeast display for engineering antibodies and related molecules.
  • To review advancements in yeast display technology for antibody engineering.

Main Methods:

  • Review of historical applications of yeast display in antibody engineering.
  • Summary of established approaches for diversity generation in yeast libraries.
  • Analysis of screening and selection strategies for yeast display libraries.

Main Results:

  • Yeast display has evolved into a premier technology for antibody engineering.
  • Developed methods improve engineered molecule quality and success rates.
  • Numerous examples demonstrate the utility of yeast display for antibody engineering.

Conclusions:

  • Yeast display is a highly effective and established technology for antibody engineering.
  • Advancements in methodology have increased its potency and reliability.
  • It remains a leading platform for antibody affinity maturation and novel antibody discovery.